ROCKVILLE, Md., Mar. 15, 2022 – OncoC4, Inc. is recognized by Pharma Tech Outlook as one of the “Top 10 Immunotherapy Solutions Providers – 2022”.
Full article can be found here: “OncoC4: Breaking Drug Resistance with Next-Gen Immunotherapy”
ROCKVILLE, Md., Mar. 15, 2022 – OncoC4, Inc. is recognized by Pharma Tech Outlook as one of the “Top 10 Immunotherapy Solutions Providers – 2022”.
Full article can be found here: “OncoC4: Breaking Drug Resistance with Next-Gen Immunotherapy”